Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P44
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -4.53% |
| Q3 2025 | -29.39% |
| Q2 2025 | -4.13% |
| Q1 2025 | 46.20% |
| Q4 2024 | -64.23% |
| Q3 2024 | -26.28% |
| Q2 2024 | 69.76% |
| Q1 2024 | -39.77% |
| Q4 2023 | -1943.02% |
| Q3 2023 | 19.75% |
| Q2 2023 | -29.12% |
| Q1 2023 | 42.58% |
| Q4 2022 | 8.75% |
| Q3 2022 | 4.39% |
| Q2 2022 | 23.41% |
| Q1 2022 | -48.57% |
| Q4 2021 | -1.57% |
| Q3 2021 | -34.55% |
| Q2 2021 | -47.29% |
| Q1 2021 | 4.32% |
| Q4 2020 | -44.54% |
| Q3 2020 | -3.79% |
| Q2 2020 | -2.26% |
| Q1 2020 | 8.07% |
| Q4 2019 | -6.18% |
| Q3 2019 | -14.77% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |